Professor Nadia Rosenthal
Scientific Director, The Jackson Laboratory, USA
Chair in Cardiovascular Science & Scientific Director, Imperial College London, UK
Born in the United States, Nadia Rosenthal was awarded a PhD in 1981 from Harvard Medical School and trained as a postdoctoral fellow at the National Institutes of Health. After holding academic research posts in Boston at Children’s Hospital and Boston University School of Medicine she moved to the Cardiovascular Research Center at Harvard Medical School, where she directed a biomedical research laboratory at the Massachusetts General Hospital. She co-edited the definitive text Heart Development and served for a decade on the editorial staff at the New England Journal of Medicine, where she was Consultant of Molecular Medicine and editor of the Molecular Medicine series.
Professor Rosenthal’s research focuses on the developmental genetics of heart and skeletal muscle, the molecular biology of ageing and the role of growth factors, stem cells and the immune system in tissue regeneration. She is an EMBO member, recipient of the Ferrari-Soave Prize in Cell Biology, and Doctors Honoris Causa from the Universite Pierre et Marie Curie in Paris and University of Amsterdam. She also holds a Chair in Cardiovascular Science at Imperial College London. She has served on numerous international grant review committees and advisory panels and has coordinated several major EU consortia on mouse genetics and disease models. She is a Founding Editor of Disease Models and Mechanisms and Editor-in-Chief of Differentiation.
Professor Rosenthal is a member of the Australia and New Zealand Society for Cell and Developmental Biology, for whom she designed the prestigious ANZSCDB Presidents Medal. She has been a faculty member of the Australian Developmental Biology Workshop and is a Visiting Professor at University of Western Australia. She currently holds an NHMRC Australia Fellowship.
Professor Rosenthal spearheaded the election of Australia to EMBL as its first Associate Member and served as Scientific Head of EMBL Australia. She is currently The Scientific Director at The Jackson Laboratory, USA.
Professor Stephen Badylak
Deputy Director, McGowan Institute for Regenerative Medicine, The University of Pittsburgh, USA
Director, Center for Pre-Clinical Tissue Engineering, McGowan Institute for Regenerative Medicine, The University of Pittsburgh, USA
Professor Badylak directs a laboratory focused upon the use of biologic scaffolds composed of extracellular matrix to facilitate functional tissue and organ reconstruction. Professor Badylak is the past President of the Tissue Engineering and Regenerative Medicine International Society, the author of more than 300 peer reviewed publications, and holds more than 50 issued U.S. patents and 300 patents worldwide. The focus of Professor Badylak's work has been the mechanisms by which extracellular matrix signals host tissues to promote and support functional tissue reconstruction.
Professor Stuart Forbes
Group Leader, Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, UK
Professor Eric Olson
Director, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, USA
Professor Peter Currie
Scientific Director, Australian Regenerative Medicine Institute, Australia
Faculty of Medicine, Nursing & Health Sciences, Monash University, Australia
Professor Thomas Rando
Director, The Glenn Laboratories for the Biology of Aging, Stanford University School of Medicine, USA
Professor Helen Blau
Director, Baxter Laboratory for Stem Cell Biology, Stanford University School of Medicine, USA
Professor Qi Zhou
The State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, People's Republic of China